TY  - GEN
AU  - Ozaki,Shoichi
AU  - Atsumi,Tatsuya
AU  - Hayashi,Taichi
AU  - Ishizu,Akihiro
AU  - Kobayashi,Shigeto
AU  - Kumagai,Shunichi
AU  - Kurihara,Yasuyuki
AU  - Kurokawa,Manae S
AU  - Makino,Hirofumi
AU  - Nagafuchi,Hiroko
AU  - Nakabayashi,Kimimasa
AU  - Nishimoto,Norihiro
AU  - Suka,Machi
AU  - Tomino,Yasuhiko
AU  - Yamada,Hidehiro
AU  - Yamagata,Kunihiro
AU  - Yoshida,Masaharu
AU  - Yumura,Wako
AU  - Amano,K
AU  - Arimura,Y
AU  - Hatta,K
AU  - Ito,S
AU  - Kikuchi,H
AU  - Muso,E
AU  - Nakashima,H
AU  - Ohsone,Y
AU  - Suzuki,Y
AU  - Hashimoto,H
AU  - Koyama,A
AU  - Matsuo,S
AU  - Kato,H
TI  - Severity-based treatment for Japanese patients with MPO-ANCA-associated vasculitis: the JMAAV study
SN  - 1439-7609
PY  - 2012///1106
KW  - Aged
KW  - Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
KW  - drug therapy
KW  - Antibodies, Antineutrophil Cytoplasmic
KW  - immunology
KW  - Asian People
KW  - Cyclophosphamide
KW  - therapeutic use
KW  - Female
KW  - Glucocorticoids
KW  - Humans
KW  - Immunosuppressive Agents
KW  - Japan
KW  - Male
KW  - Middle Aged
KW  - Peroxidase
KW  - Prednisolone
KW  - Remission Induction
KW  - Severity of Illness Index
KW  - Treatment Outcome
N1  - Publication Type: Clinical Trial; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1007/s10165-011-0525-5
ER  -